Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Clinical Evaluation of Fast-in-Time (FIT) Anti-CD19 CAR T-a Non-Viral, 2-Day Rapid Manufacture CAR T-Cell Therapy for B-Cell Malignancies

Ping Li, Jian Ge, Shiguang Ye, Lili Zhou, Yiming Gong, Huaying Ruan, Hosein Kouros-Mehr, Aibin Liang

Blood (2024) 144 (Supplement 1): 3475.

https://doi.org/10.1182/blood-2024-199236

Published: 2024

Journal Articles

Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency

Blood (2023) 142 (Supplement 1): 6810.

https://doi.org/10.1182/blood-2023-188264

Published: 2023

Journal Articles

Feasibility of Extracorporeal Delivery of Fusosomes to Generate CAR T Cells In Vivo

Jesse Green, Andrew Tucker, Aesha Vakil, Matt Scott-Skandera, Vasily Vagin, Dharmesh Dingar, Tarik Elgendi, Christina Proano, Brian Dolinski, Matthew A Lunning, Scott A Koepsell, Charles A Branson, Kerrie Enger, Danielle Quarles, Hosein Kouros-Mehr, Sarah Miller, Misha Shamashkin, Kutlu G Elpek

Blood (2023) 142 (Supplement 1): 3631.

https://doi.org/10.1182/blood-2023-186317

Published: 2023

Journal Articles

Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data

Sattva S. Neelapu, L. Elizabeth Budde, Joseph P McGuirk, Saurabh Dahiya, Abhinav Deol, Philip A. Thompson, Nitin Jain, Matthew A Lunning, Xiaomeng Hu, Boris Gorovits, Danielle Quarles, Barbara Metallo, Meghan Flaherty, Weidong Zhang, Hosein Kouros-Mehr, Terry J. Fry, Sonja Schrepfer

Blood (2023) 142 (Supplement 1): 6852.

https://doi.org/10.1182/blood-2023-179441

Published: 2023